HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,161-2,172 of 4,505
Drug study icon
CompletedNCT01346163

Add On Treatment for Cognitive Deficits in Schizophrenia

Official study title

A Phase1B Study: A Placebo Controlled Study of PF-03654746 Given as Add-On Treatment of Cognitive Deficits in Schizophrenia

This study has finished and is no longer accepting participants.

In Philadelphia
SchizophreniaMedication studyAges 18–40
Countries
United States
Sponsor
University of Pennsylvania
Drug study icon
TerminatedNCT00605995

Add-on Simvastatin in Schizophrenia study

Official study title

Add-on Simvastatin in Schizophrenia Trial

This study ended early.

In Ramat Gan
SchizophreniaMedication studyAges 18–70
Countries
Israel
Sponsor
New York State Psychiatric Institute
Drug study icon
CompletedNCT01548612

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

Official study title

Randomised Double Blind Placebo Controlled Study of Sodium Nitroprusside Added to Treatment as Usual in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Ribeirão Preto
SchizophreniaMedication studyAges 18–45
Countries
Brazil
Sponsor
University of Sao Paulo
Drug study icon
CompletedNCT01189006

Add-On Therapy to Risperidonein Schizophrenia

What is this study about?

This study evaluated the effectiveness of Dextromethorphan for people with schizophrenia.

This study has finished and is no longer accepting participants.

In Tainan
SchizophreniaMedication studyAges 18–65
Countries
Taiwan
Sponsor
National Cheng-Kung University Hospital
Drug study icon
CompletedNCT02751307

Adjunctive Low-dose Metformin in people with Schizophrenia and Metabolic Abnormalities

Official study title

Treatment of Metabolic Abnormalities in Patients With Schizophrenia: Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 20–65
Countries
Sponsor
Taipei Medical University WanFang Hospital

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.